| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 12/24/2008 | CN100444846C Dispersion tablet contg. Gynostemma petaphylla total glucosides, and its prepn. method |
| 12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |
| 12/24/2008 | CN100444834C Effervescence tablet for treating wind-cold type cold and preparation process thereof |
| 12/24/2008 | CN100444832C A medicine for treating pharyngitis |
| 12/24/2008 | CN100444831C Compound dripping pills of licorice and its preparing process |
| 12/24/2008 | CN100444830C Multiparticulate modified release composition |
| 12/24/2008 | CA2721135A1 A zwitterion solution for low-volume therapeutic delivery |
| 12/24/2008 | CA2692249A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | CA2692248A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | CA2691991A1 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors |
| 12/24/2008 | CA2691654A1 Treatment of meconium aspiration syndrome with estrogens |
| 12/24/2008 | CA2691379A1 Substituted n-aryl pyridinones |
| 12/24/2008 | CA2690436A1 Amine salts of a crth2 antagonist |
| 12/24/2008 | CA2690172A1 Particulates of a crth2 antagonist |
| 12/23/2008 | US7468388 Using 5-aceylamino-4-azido-4-nitrophenoxycarbonyloyl) -(2-oxo (1,3-dioxolan-4-yl)-5,6-dihydropyran-2-carxylic acid methyl ester; therapy for myxovirus infections; active materials; stability; long time in lungs |
| 12/23/2008 | US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression; |
| 12/23/2008 | US7468270 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 12/23/2008 | US7468264 Application of specific and selective fields generated by specific and selective electric and/or electromagnetic signals, and determining the voltage and current of the signal to apply to electrodes or coils applied to the knee for treatment of human knee injury or defect |
| 12/23/2008 | CA2426074C Inhalable formulation of a solution containing a tiotropium salt |
| 12/23/2008 | CA2424664C Novel non-imidazole compounds |
| 12/23/2008 | CA2245267C Crystal form of n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 12/18/2008 | WO2008153027A1 Pyrroloquinoline derivative and use thereof |
| 12/18/2008 | WO2008152142A1 2 -aminoquinazoline derivatives and their therapeutic uses |
| 12/18/2008 | WO2008151519A1 USE OF NARINGENIN AND NARINGIN AS INHIBITORS FOR TRANSFORMING GROWTH FACTOR-β1 SIGNALING PATHWAY |
| 12/18/2008 | WO2008151428A1 Novel compositions for modulating mrna translation |
| 12/18/2008 | US20080312412 Chimeric protein including a protein from parainfluenza virus and a protein from respiratory syncytial virus, capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV); vaccines |
| 12/18/2008 | US20080312336 Preventive and/or Therapeutic Agent for Diabetic Vascular Disorder and Respiratory Disorder |
| 12/18/2008 | US20080312324 Treatment of lung cells with histone deacetylase inhibitors |
| 12/18/2008 | US20080312311 Crystalline forms of 3-(2R-tetrahydrofuryl-methyl)-2-thioxanthine |
| 12/18/2008 | US20080312307 Mapk/erk kinase inhibitors |
| 12/18/2008 | US20080312285 Substituted Indazoles as Inhibitors of Phosphodiesterase Type-Iv |
| 12/18/2008 | US20080312270 Compounds and methods useful for treating asthma and allergic inflammation |
| 12/18/2008 | US20080312269 Therapeutic Agents |
| 12/18/2008 | US20080312233 Therapeutic Morpholino-Substituted Compounds |
| 12/18/2008 | US20080312212 Organic Compounds |
| 12/18/2008 | US20080312168 Novel Dispersible Tablet Composition |
| 12/18/2008 | US20080312163 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors |
| 12/18/2008 | US20080312136 Alpha 1-Antitrypsin Compositions and Treatment Methods Using Such Compositions |
| 12/18/2008 | US20080311624 Chimeric immunogens |
| 12/18/2008 | US20080311217 Topicial composition for treating pain |
| 12/18/2008 | US20080311201 Modified release solid or semi-solid dosage forms |
| 12/18/2008 | US20080311196 All Day Rhinitic Condition Treatment Regimen |
| 12/18/2008 | US20080311167 Topical Composition for Treating Pain |
| 12/18/2008 | US20080311128 Method for Treating Pathological Pulmonary Conditions and Bleomycin Associated Pulmonary Fibrosis |
| 12/18/2008 | US20080311118 Vascular endothelial cell growth factor antagonists and uses thereof |
| 12/18/2008 | US20080311111 Competitive Domain Antibody Formats That Bind Interleukin 1 Receptor Type 1 |
| 12/18/2008 | US20080311089 Augmentation and Repair of Vocal Cord Tissue Defects |
| 12/18/2008 | US20080311088 Method of Treating Lung Diseases Using Cells Separated Or Proliferated From Umbilical Cord Blood |
| 12/18/2008 | US20080311052 Isis Pharmaceuticals, Inc. |
| 12/17/2008 | EP2002845A2 Combinations comprising antimuscarinic agents and corticosteroids |
| 12/17/2008 | EP2002844A2 Combinations comprising antimuscarininc agents and beta-adrenergic agonists |
| 12/17/2008 | EP2002843A2 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 12/17/2008 | EP2002837A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 12/17/2008 | EP2002832A2 Composition containing lignan compound |
| 12/17/2008 | EP2002831A1 R-Bambuterol, its preparation and therapeutic uses |
| 12/17/2008 | EP2002733A1 Natural honey-containing compositions and method of preparation |
| 12/17/2008 | EP2001881A2 Compositions and methods for treating respiratory disorders |
| 12/17/2008 | EP2001466A2 Formulations and methods for vascular permeability-related diseases or conditions |
| 12/17/2008 | EP2001454A2 Use of at least one cytosolic phospholipase a2 inhibitor as a medicine for symptomatic treatment of mucoviscidosis |
| 12/17/2008 | EP1809607B1 Sulfonyl benzimidazole derivatives |
| 12/17/2008 | EP1763369B1 Combinations comprising antimuscarinic agents and corticosteroids |
| 12/17/2008 | EP1763342B1 Sphingolipids against pathological processes in lipid rafts |
| 12/17/2008 | EP1425001B1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 12/17/2008 | EP1230214B1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 12/17/2008 | EP1077943B1 Heterocyclic inhibitors of p38 |
| 12/17/2008 | CN101326181A Imidazopyridine derivatives as a2b adenosine receptor antagonists |
| 12/17/2008 | CN101325973A Use of oligouronates for treating mucus hyperviscosity |
| 12/17/2008 | CN101322811A Chinese medicine for treating epistaxis |
| 12/17/2008 | CN101322810A Chinese traditional medicine composition for treating diabetes respiratory tract infection |
| 12/17/2008 | CN101322798A Snake bile and Sichuan fritillaria bulb lozenge and preparation thereof |
| 12/17/2008 | CN101322783A Chinese medicine compound volatile oil part for treating asthma and preparation thereof |
| 12/17/2008 | CN101322781A Capsules for treating laryngopharyngitis |
| 12/17/2008 | CN101322776A Chinese medicinal composition for treating exogenous fever and preparation thereof |
| 12/17/2008 | CN101322770A Compound creat formulation for resisting infection |
| 12/17/2008 | CN101322763A Specific external-use medicament for treating allergic rhinitis |
| 12/17/2008 | CN101322761A Medicament for treating tracheitis and bronchitic and preparation thereof |
| 12/17/2008 | CN101322759A Medicament for treating coryza and preparation thereof |
| 12/17/2008 | CN101322749A Chinese medicine oral liquid for treating wind-heat cold and preparation thereof |
| 12/17/2008 | CN101322745A Medicament for treating inflammation |
| 12/17/2008 | CN101322744A Specific external-use medicament for treating nasal sinusitis |
| 12/17/2008 | CN101322734A Codonopsis lanceolata total saponins with antiinflammatory immunity function and preparation thereof |
| 12/17/2008 | CN101322733A Chinese herbal medicine formulation for treating pollution lung disease |
| 12/17/2008 | CN101322732A Method for processing asarum herb |
| 12/17/2008 | CN101322708A Extended release oral dosage composition |
| 12/17/2008 | CN101322700A Applications of naringenin and naringin as signal pathway inhibitor of transforming growth factor-beta 1 |
| 12/17/2008 | CN100443481C Imidazolyl-cyclic acetals |
| 12/17/2008 | CN100443479C 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 12/17/2008 | CN100443477C Substituted benzoxazoles and analogues as estrogenic agents |
| 12/17/2008 | CN100443119C Inhalation of nitric oxide |
| 12/17/2008 | CN100443108C Plaster for treating pneumonia and tracheitis and its preparing method |
| 12/17/2008 | CN100443076C Babu agent of Chinese traditional medicine for treating asthma and preparation method |
| 12/17/2008 | CN100443073C Chinese Apea Ear-ring preparation capable of improving drug effect and preparation method thereof |
| 12/16/2008 | US7465831 Levalbuterol hydrochloride Polymorph A |
| 12/16/2008 | US7465815 Cannabinoid receptor modulator |
| 12/16/2008 | US7465756 Bronchodilating beta-agonist compositions and methods |
| 12/16/2008 | US7465751 respiratory, urinary and gastrointestinal systems disorders; 2-cyclopentyl-2-hydroxy-N-[(3S)-1-benzyl-pyrrolidin-3-yl]-2-phenyl acetamide; side effects reduction; compounds exhibit significant potency |
| 12/16/2008 | US7465736 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 12/16/2008 | US7465728 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity |
| 12/16/2008 | US7465718 Ansamycins having improved pharmacological and biological properties |
| 12/16/2008 | US7465548 associated with the disorders of the peripheral and central nervous system, cardiovascular diseases, hematological diseases, cancer, inflammation, urological diseases, respiratory diseases and gastroenterological diseases |